Partners Highlights: March 2021

Blackford Analysis March 31, 2021

Here’s the latest instalment in our news updates from Blackford Platform Partners.

Lung analysis firm VIDA published a new blog post exploring how major regulators like the United States FDA intends to regulate AI. Key quote: “… an important focus of regulators must be: how do we facilitate the introduction of safe and effective AI technologies to market?” Computer aided diagnostics company AZmed posted a new video interview featuring CEO Julien Vidal. In it, he talks about the advantages of Rayvolve and how it helps physicians in emergency environments. Neurodegenerative disease assessment specialist Cortechs.ai published a case study featuring Imaging Healthcare Specialists, which has become the first outpatient imaging provider to adopt OnQ Prostate as part of all clinically routine prostate MRI exams. Musculoskeletal AI solutions developer Image Biopsy Lab revealed it was the subject of a new video by MSK radiologist Christoph Agten, MD. In the video, Dr Agten and machine learning expert Christoph Haarburger reviewed IB Lab HIPPO, one of the company’s four AI-driven software solutions for automated measurements on radiographs. Test Image Biopsy Lab’s AI tools with your own radiographs here. Following Accipio Ax approvals in the EU and Australia, medical diagnostic provider MaxQ secured regulatory approval for Accipio Dxg (negative triage) in the same regions. MaxQ is the only provider of positive triage, annotation, and negative triage for ICH in stroke and head trauma, providing a comprehensive workflow with native real-time prioritization and seamless workflow via Blackford. And finally, medical 3D printing specialist Axial3D announced 300% growth, despite the pandemic, alongside a new £3 million investment round and plans to grow its workforce in Northern Ireland. Stay tuned for more partner news next month!